CAC2 Childhood Cancer Community News Digest (December 16-22)
Assorted News from the Last Week:
Special Advocacy Call to Action: CAC2 Supporting Organization LLS is spearheading an effort and inviting all in the community to call on Congress to make children with cancer its number one priority when it reconvenes in January. Read about it here.
FDA approves Remestemcel-L for pediatric steroid-refractory acute Graft-vs-Host disease.
Alarming mental health challenges among young cancer survivors, especially males, demand action.
Giving pediatric cancer survivors hope in Nigeria.
Breakthrough study set to change how osteosarcomas are diagnosed and treated.
Neurocognitive battery feasible in 3-year-olds during leukemia treatment.
Helping kids with cancer speak for the supportive care they need.
NCI Director Kimryn Rathnell’s first year reflection: “One Year in Cancer Research and Much to Celebrate“.
Upcoming Webinars, Online Opportunities, and Meetings:
ACCELERATE Multi-stakeholder Conference “A Decade of Impact – and Beyond” on February 6th & 7th in Brussels Belgium. In-person and virtual registration available. Click here for more information and to register.
The 2nd Childhood Cancer Prevention Symposium will be held in Houston, TX, at Texas Children’s Hospital, February 10-13, 2025. Click here for more information and to register.
Take Action:
SUBSCRIBE
Sign up to receive a copy of CAC2's free childhood cancer news digest in your inbox each week.
Categories
- Blog Posts (98)
- Explainer Post (12)
- Guest Blogs (16)
- Member Blogs (40)
- Survivorship Matters Blog (9)
- CAC2 News (25)
- Collaborative Achievements (14)
- Community News (258)
- In Memoriam (2)
- News Digest (207)
- Webinars (64)